Altimmune, Inc. (ALT)

4.175 +0.16 (+4.11%) USD  |  NASDAQ  |  Jan 14, 16:00
4.175 0.00 (0.00%) After-Hours: 19:44
More

Altimmune Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for ALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Viking Therapeutics, Inc. Upgrade
CorMedix, Inc. Upgrade
Seres Therapeutics, Inc. Upgrade
Rhythm Pharmaceuticals, Inc. Upgrade
Terns Pharmaceuticals, Inc. Upgrade